Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.

This study compares a generic version of aripiprazole injection (400 mg) to the brand-name drug Abilify Maintena® in people with stable schizophrenia. About 116 participants will receive five shots of each drug, one month apart, to see if the generic works the same in the body. T…

This study tests an injection called SYH2053 in 135 adults with heterozygous familial hypercholesterolemia (HeFH), an inherited condition causing very high cholesterol and heart disease risk. Participants must already be on a stable statin and low-fat diet. The main goal is to se…

This study tests a new injection called SYH2053 for people with high cholesterol (non-familial) or mixed high blood fats. About 900 adults aged 18-75 who are already on cholesterol-lowering medication will receive either the study drug or a placebo. The main goal is to see if SYH…

This early-phase study tests the safety of a new drug called SYH2061 in 40 healthy adults aged 18 to 55. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure how the drug moves through the body. The goal is to gather initial safe…